Bardazid ApS was established back in November 2019. The technology itself was a spinoff from the subsidiary company called LiquidVanity ApS, which holds the extensive basic patent for the technology which is the basis for the Baradazid novel disinfectant  – the Bardazid-Surface™.

Both LiquidVanity ApS and Bardazid ApS were founded by the same team: 

Dan Nyenstad Mønster, CEO and entrepreneur with extensive experience in idea development and application methodologies.

 Per Bendix Jeppesen, Associate Prof., PhD. at Aarhus University, Department of Clinical Medicine, has many years of experience in drug development as well as a basic knowledge of chemistry, and has been involved in several international drug developments as a clinical manager. 

Torben Ballegaard Sørensen, has a long career in business development and has held several CEO and board positions.

The technology is developed and based on combating pathogenic microorganisms and was initially based on removing these pathogenic microorganisms in delicate textiles at low temperatures, but technology proved to be so unique that it can be used for other purposes, including as a non-alcohol disinfectant with detergent effect.

Later, one highly reputated investor has joined the firm.